-DOCSTART- -X- O
SARS-CoV-2 -X- _ O
is -X- _ O
a -X- _ O
newly -X- _ O
emerging -X- _ O
human -X- _ O
infectious -X- _ O
coronavirus -X- _ O
that -X- _ O
causes -X- _ O
COVID-19 -X- _ B-Patient
, -X- _ O
which -X- _ O
has -X- _ O
been -X- _ O
recognized -X- _ O
as -X- _ O
a -X- _ O
pandemic -X- _ O
by -X- _ O
the -X- _ O
World -X- _ O
Health -X- _ O
Organization -X- _ O
( -X- _ O
WHO -X- _ O
) -X- _ O
on -X- _ O
March -X- _ O
11 -X- _ O
( -X- _ O
th -X- _ O
) -X- _ O
. -X- _ O
There -X- _ O
is -X- _ O
still -X- _ O
no -X- _ B-Outcome
vaccine -X- _ I-Outcome
or -X- _ I-Outcome
definitive -X- _ I-Outcome
treatment -X- _ I-Outcome
for -X- _ I-Outcome
this -X- _ I-Outcome
virus -X- _ I-Outcome
because -X- _ I-Outcome
its -X- _ I-Outcome
pathogenesis -X- _ I-Outcome
and -X- _ I-Outcome
proliferation -X- _ I-Outcome
pathways -X- _ I-Outcome
are -X- _ I-Outcome
still -X- _ I-Outcome
unknown. -X- _ I-Outcome
Therefore -X- _ O
, -X- _ O
in -X- _ O
this -X- _ O
article -X- _ O
, -X- _ O
new -X- _ O
potential -X- _ O
COVID-19 -X- _ B-Intervention
therapies -X- _ I-Intervention
are -X- _ O
briefly -X- _ O
reviewed -X- _ O
. -X- _ O

